We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$36.9B
AUM Growth
-$216M
(-0.58%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
8.45%
Holding
2,522
New
303
Increased
944
Reduced
1,005
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$240M |
| 3 |
Chevron
CVX
|
+$231M |
| 4 |
Amazon
AMZN
|
+$183M |
| 5 |
Citigroup
C
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$277M |
| 2 |
Lowe's Companies
LOW
|
+$253M |
| 3 |
Home Depot
HD
|
+$246M |
| 4 |
Danaher
DHR
|
+$174M |
| 5 |
Cisco
CSCO
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.03% |
| 2 | Technology | 15.23% |
| 3 | Healthcare | 11.73% |
| 4 | Industrials | 11.36% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Vitamin Cottage Natural Grocers
NGVC
$729M
| $606K | ﹤0.01% |
84,600
-40,000
| -32% | -$307K |
|
1752
Cytokinetics
CYTK
$10.9B
| $605K | ﹤0.01% |
84,000
+9,200
| +12% | +$78.9K |
|
1753
IMAX
IMAX
$2.47B
| $605K | ﹤0.01% |
+31,500
| New | +$655K |
|
|
PTVCB
1754
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $605K | ﹤0.01% |
27,501
+600
| +2% | +$13.9K |
|
|
GLDD
1755
DELISTED
Great Lakes Dredge & Dock
GLDD
| $602K | ﹤0.01% |
130,867
-13,900
| -10% | -$65.9K |
|
|
AVID
1756
DELISTED
Avid Technology Inc
AVID
| $600K | ﹤0.01% |
132,241
-51,000
| -28% | -$259K |
|
|
HBI
1757
DELISTED
Hanesbrands
HBI
| $599K | ﹤0.01% |
+32,498
| New | +$671K |
|
|
BRSL
1758
Brightstar Lottery PLC
BRSL
$1.93B
| $594K | ﹤0.01% |
22,238
-61,200
| -73% | -$1.7M |
|
1759
PagSeguro Digital
PAGS
$2.62B
| $590K | ﹤0.01% |
+15,400
| New | +$494K |
|
1760
Hanmi Financial
HAFC
$942M
| $585K | ﹤0.01% |
19,035
-2,400
| -11% | -$74.9K |
|
|
AVYA
1761
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $585K | ﹤0.01% |
+26,100
| New | +$558K |
|
|
BFIN
1762
DELISTED
BankFinancial
BFIN
| $584K | ﹤0.01% |
34,388
-3,800
| -10% | -$60.8K |
|
|
UNT
1763
DELISTED
UNIT Corporation
UNT
| $579K | ﹤0.01% |
29,308
+17,681
| +152% | +$385K |
|
1764
Q2 Holdings
QTWO
$3.64B
| $578K | ﹤0.01% |
+12,700
| New | +$548K |
|
1765
Microchip Technology
MCHP
$42.3B
| $575K | ﹤0.01% |
+12,586
| New | +$580K |
|
|
GCP
1766
DELISTED
GCP Applied Technologies Inc.
GCP
| $575K | ﹤0.01% |
+19,800
| New | +$638K |
|
|
FTD
1767
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $575K | ﹤0.01% |
158,100
-10,800
| -6% | -$64.8K |
|
|
SEAC
1768
DELISTED
Seachange International Inc
SEAC
| $566K | ﹤0.01% |
10,445
+1,992
| +24% | +$130K |
|
|
DERM
1769
DELISTED
Dermira, Inc.
DERM
| $566K | ﹤0.01% |
70,900
+62,900
| +786% | +$1.37M |
|
|
PBT
1770
Permian Basin Royalty Trust
PBT
$1.29B
| $565K | ﹤0.01% |
58,533
-18,800
| -24% | -$175K |
|
|
ENZ
1771
DELISTED
Enzo Biochem, Inc.
ENZ
| $556K | ﹤0.01% |
101,473
| – | – |
|
|
IMDZ
1772
DELISTED
Immune Design Corp.
IMDZ
| $556K | ﹤0.01% |
168,600
+53,600
| +47% | +$190K |
|
1773
Liquidity Services
LQDT
$1.21B
| $554K | ﹤0.01% |
85,218
+2,400
| +3% | +$15.2K |
|
1774
Matthews International
MATW
$878M
| $552K | ﹤0.01% |
10,915
-9,400
| -46% | -$499K |
|
1775
Regenxbio
RGNX
$622M
| $552K | ﹤0.01% |
18,500
-3,576
| -16% | -$104K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Two Sigma Advisers held 2,522 positions worth $36.9B, down 0.58% from $37.1B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Two Sigma Advisers's Q1 2018 filing shows 303 new, 944 increased, 1,005 reduced and 237 closed positions. Its largest new stake was Procter & Gamble: 3,490,366 shares worth $277M. The largest sale was Amgen, an estimated $277M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Two Sigma Advisers's largest Q1 2018 buy was Procter & Gamble: 3,490,366 shares worth $277M.
- Two Sigma Advisers added most to PepsiCo in Q1 2018, an estimated $240M increase.
- Two Sigma Advisers's biggest Q1 2018 reduction was Amgen, cutting an estimated $277M.
- Two Sigma Advisers fully exited Constellation Brands in Q1 2018, selling an estimated $115M.
- Two Sigma Advisers's ten largest holdings make up 8.4% of its $36.9B portfolio in Q1 2018.
- Two Sigma Advisers opened 303 new positions and closed 237 in Q1 2018.
- Two Sigma Advisers's portfolio value fell 0.58% quarter-over-quarter to $36.9B.
Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.